Physician profile
Ralph L Corsetti
NPI 1750341863
$29,458.29
in general payments reported to CMS, 2019-2025
23 companies · $20K in 2025
The $20K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $216 · 2021: $2,180 · 2022: $1,600 · 2023: $3,333 · 2024: $2,141 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Honoraria: $1,638 · Food and Beverage: $1,527 · Travel and Lodging: $1,357 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $480 · Entertainment: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,005.00 |
| Honoraria | $1,637.50 |
| Food and Beverage | $1,526.99 |
| Travel and Lodging | $1,356.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $480.00 |
| Entertainment | $274.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $23,651.41 | 2020-2025 | Savi Scout |
| Kub Technologies INC. | $3,572.54 | 2021-2024 | Mozart |
| Myriad Genetic Laboratories, INC. | $865.61 | 2021-2024 | Myrisk, Precisetumor |
| Kerecis Limited | $506.46 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Stryker Corporation | $148.85 | 2019 | |
| Medtronic USA, INC. | $128.55 | 2020 | |
| Medtronic, INC. | $86.52 | 2021-2025 | Interstim |
| Dilon Technologies, INC. | $77.20 | 2024-2025 | Hemoblast Bellows |
| Hologic INC | $58.59 | 2022 | |
| Sirius Medical Systems | $56.53 | 2024 | Pintuition |
| Genentech USA, INC. | $47.20 | 2019-2023 | Perjeta |
| Molli Surgical (US) INC | $41.84 | 2023 | |
| Biotissue Holdings INC. | $37.10 | 2022 | |
| Acera Surgical, INC. | $23.13 | 2024 | Restrata Wound Matrix |
| Springworks Therapeutics, INC. | $22.86 | 2025 | Ogsiveo |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elucent Medical | $20.76 | 2024 | |
| Hologic Sales and Service, LLC | $20.04 | 2023 | Sertera Biopsy Device |
| Astrazeneca Pharmaceuticals LP | $18.05 | 2023 | Enhertu |
| Smith+Nephew, INC. | $17.78 | 2025 | Renasys Touch, Pico 14 |
| Tactile Systems Technology INC | $15.73 | 2021 | |
| Kci USA, INC. | $14.71 | 2023 | Activ.A.C., V.A.C. Veraflo, Prevena |
| Leo Pharma INC. | $13.48 | 2019 | |
| Baxter Healthcare | $13.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Corsetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.